应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
NRBO NeuroBo Pharmaceuticals, Inc.
未开盘 07-02 16:00:00 EDT
4.68
+0.14
+3.08%
盘后
4.61
-0.07
-1.50%
19:59 EDT
最高
4.79
最低
4.25
成交量
6.17万
今开
4.73
昨收
4.54
日振幅
11.96%
总市值
2,653万
流通市值
63.37万
总股本
566.94万
成交额
28.29万
换手率
45.60%
流通股本
13.54万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Neurobo Pharmaceuticals, Inc.盘中异动 临近收盘股价大跌5.79%报4.56美元
自选股智能写手 · 07-02 03:43
Neurobo Pharmaceuticals, Inc.盘中异动 临近收盘股价大跌5.79%报4.56美元
Neurobo Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.38%
自选股智能写手 · 06-27
Neurobo Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.38%
Neurobo Pharmaceuticals, Inc.盘中异动 急速拉升15.96%
自选股智能写手 · 06-26
Neurobo Pharmaceuticals, Inc.盘中异动 急速拉升15.96%
Neurobo Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.39%报3.86美元
自选股智能写手 · 06-25
Neurobo Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.39%报3.86美元
Neurobo Pharmaceuticals, Inc.股价重挫17.44% 市值跌286.78万美元
自选股智能写手 · 06-24
Neurobo Pharmaceuticals, Inc.股价重挫17.44% 市值跌286.78万美元
Neurobo Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.15%报3.63美元
自选股智能写手 · 06-19
Neurobo Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.15%报3.63美元
Neurobo Pharmaceuticals, Inc.盘中异动 股价大跌6.47%报3.90美元
自选股智能写手 · 05-29
Neurobo Pharmaceuticals, Inc.盘中异动 股价大跌6.47%报3.90美元
Neurobo Pharmaceuticals, Inc.盘中异动 股价大涨5.93%
自选股智能写手 · 05-28
Neurobo Pharmaceuticals, Inc.盘中异动 股价大涨5.93%
Neurobo Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.24%
自选股智能写手 · 05-22
Neurobo Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.24%
Neurobo Pharmaceuticals, Inc.盘中异动 股价大涨8.53%报3.69美元
自选股智能写手 · 04-17
Neurobo Pharmaceuticals, Inc.盘中异动 股价大涨8.53%报3.69美元
加载更多
公司概况
公司名称:
NeuroBo Pharmaceuticals, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
NeuroBo Pharmaceuticals, Inc.于2008年11月10日在密歇根以Michigan Life Therapeutics, LLC (MLT)这个名字注册成立。NeuroBo Pharmaceuticals, Inc.是一家临床阶段的生物技术公司,主要致力于开发和商业化治疗心脏代谢疾病的新药物。NeuroBo有两个主要项目,重点治疗非酒精性脂肪性肝炎(NASH)、肥胖症和2型糖尿病(T2D)。
发行价格:
--
{"stockData":{"symbol":"NRBO","market":"US","secType":"STK","nameCN":"NeuroBo Pharmaceuticals, Inc.","latestPrice":4.68,"timestamp":1719950400000,"preClose":4.54,"halted":0,"volume":61741,"hourTrading":{"tag":"盘后","latestPrice":4.61,"preClose":4.68,"latestTime":"19:59 EDT","volume":580,"amount":2703.3625,"timestamp":1719964765895},"delay":0,"floatShares":135400,"shares":5669400,"eps":-3.271078,"marketStatus":"未开盘","marketStatusCode":0,"change":0.14,"latestTime":"07-02 16:00:00 EDT","open":4.73,"high":4.793,"low":4.25,"amount":282938.25802400004,"amplitude":0.119604,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.271078,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1719993600000},"adr":0,"listingDate":1470369600000,"adjPreClose":4.54,"preHourTrading":{"tag":"盘前","latestPrice":4.58,"preClose":4.54,"latestTime":"09:10 EDT","volume":301,"amount":1371.7172,"timestamp":1719925810656},"postHourTrading":{"tag":"盘后","latestPrice":4.61,"preClose":4.68,"latestTime":"19:59 EDT","volume":580,"amount":2703.3625,"timestamp":1719964765895},"volumeRatio":0.236659,"impliedVol":3.214,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/NRBO","defaultTab":"news","newsList":[{"id":"2448944298","title":"Neurobo Pharmaceuticals, Inc.盘中异动 临近收盘股价大跌5.79%报4.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448944298","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448944298?lang=zh_cn&edition=full","pubTime":"2024-07-02 03:43","pubTimestamp":1719862985,"startTime":"0","endTime":"0","summary":"北京时间2024年07月02日03时43分,Neurobo Pharmaceuticals, Inc.股票出现波动,股价大幅下挫5.79%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.78%。其相关个股中,Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Senti Biosciences, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 涨幅较大,Senti Biosciences, Inc.、Geovax Labs, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃,换手率分别为833.90%、208.74%、133.68%,振幅较大的相关个股有Senti Biosciences, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Cingulate Inc.,振幅分别为101.49%、83.23%、82.81%。Neurobo Pharmaceuticals, Inc.公司简介:NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司,主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702034305941f2cfa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702034305941f2cfa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4202","BK4139","OXM","NRBO"],"gpt_icon":0},{"id":"2446556737","title":"Neurobo Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446556737","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446556737?lang=zh_cn&edition=full","pubTime":"2024-06-27 22:14","pubTimestamp":1719497690,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日22时14分,Neurobo Pharmaceuticals, Inc.股票出现异动,股价急速拉升5.38%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.33%。其相关个股中,Geovax Labs Inc C/Wts 29/09/2025、Geovax Labs, Inc.、Nls Pharmaceutics Ltd.涨幅较大,Geovax Labs, Inc.、Nls Pharmaceutics Ltd.、Kala Bio, Inc.较为活跃,换手率分别为1317.83%、236.87%、231.22%,振幅较大的相关个股有Geovax Labs, Inc.、Geovax Labs Inc C/Wts 29/09/2025、Nls Pharmaceutics Ltd.,振幅分别为124.57%、112.22%、79.30%。Neurobo Pharmaceuticals, Inc.公司简介:NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司,主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627221450941f1d53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627221450941f1d53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4202","BK4139","NRBO","OXM"],"gpt_icon":0},{"id":"2446539611","title":"Neurobo Pharmaceuticals, Inc.盘中异动 急速拉升15.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446539611","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446539611?lang=zh_cn&edition=full","pubTime":"2024-06-26 21:31","pubTimestamp":1719408703,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日21时31分,Neurobo Pharmaceuticals, Inc.股票出现异动,股价急速拉升15.96%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.52%。其相关个股中,Anew Medical, Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 、Conduit Pharmaceuticals Inc.涨幅较大,Anew Medical, Inc.、Cns Pharmaceuticals, Inc.、Gri Bio, Inc.较为活跃,换手率分别为280.96%、60.33%、58.54%,振幅较大的相关个股有Anew Medical, Inc.、Atossa Therapeutics, Inc.、Conduit Pharmaceuticals Inc.,振幅分别为34.21%、20.87%、19.51%。Neurobo Pharmaceuticals, Inc.公司简介:NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司,主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406262131439f67f264&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406262131439f67f264&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRBO","BK4202","BK4139","OXM"],"gpt_icon":0},{"id":"2446429138","title":"Neurobo Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.39%报3.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446429138","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446429138?lang=zh_cn&edition=full","pubTime":"2024-06-25 22:21","pubTimestamp":1719325270,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日22时21分,Neurobo Pharmaceuticals, Inc.股票出现异动,股价快速下挫5.39%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为1.62%。其相关个股中,Estrella Immunopharma Inc C/Wts 29/09/2028、Glycomimetics, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 涨幅较大,Effector Therapeutics, Inc.、Glycomimetics, Inc.、Allarity Therapeutics, Inc.较为活跃,换手率分别为169.82%、143.60%、84.80%,振幅较大的相关个股有Glycomimetics, Inc.、Effector Therapeutics, Inc.、Senti Biosciences, Inc.,振幅分别为37.88%、34.24%、33.10%。Neurobo Pharmaceuticals, Inc.公司简介:NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司,主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625222110941f0f30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625222110941f0f30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRBO","BK4139","BK4202","OXM"],"gpt_icon":0},{"id":"2445518072","title":"Neurobo Pharmaceuticals, Inc.股价重挫17.44% 市值跌286.78万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445518072","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445518072?lang=zh_cn&edition=full","pubTime":"2024-06-24 21:31","pubTimestamp":1719235904,"startTime":"0","endTime":"0","summary":"北京时间2024年06月24日21时31分,Neurobo Pharmaceuticals, Inc.股票出现波动,股价快速下挫17.44%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.89%。其相关个股中,Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Revelation Biosciences, Inc.、阿里拉姆制药涨幅较大,Revelation Biosciences, Inc.、Gri Bio, Inc.、Effector Therapeutics, Inc.较为活跃,换手率分别为261.47%、42.66%、30.54%,振幅较大的相关个股有Revelation Biosciences, Inc.、Psyence Biomedical Ltd.、G1 Therapeutics, Inc.,振幅分别为15.17%、11.62%、10.20%。Neurobo Pharmaceuticals, Inc.公司简介:NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司,主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406242131459f60005b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406242131459f60005b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OXM","BK4202","BK4139","NRBO"],"gpt_icon":0},{"id":"2444454754","title":"Neurobo Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.15%报3.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444454754","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444454754?lang=zh_cn&edition=full","pubTime":"2024-06-19 02:50","pubTimestamp":1718736652,"startTime":"0","endTime":"0","summary":"北京时间2024年06月19日02时50分,Neurobo Pharmaceuticals, Inc.股票出现波动,股价快速下跌5.15%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.57%。其相关个股中,Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Geovax Labs Inc C/Wts 29/09/2025、Nls Pharmaceutics Ltd.涨幅较大,Mustang Bio, Inc.、Geovax Labs, Inc.、Nls Pharmaceutics Ltd.较为活跃,换手率分别为912.94%、856.05%、672.45%,振幅较大的相关个股有Nls Pharmaceutics Ltd.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Geovax Labs, Inc.,振幅分别为154.62%、134.50%、115.30%。Neurobo Pharmaceuticals, Inc.公司简介:NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司,主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240619025052aef57cb6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240619025052aef57cb6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRBO","BK4139","OXM","BK4202"],"gpt_icon":0},{"id":"2439574439","title":"Neurobo Pharmaceuticals, Inc.盘中异动 股价大跌6.47%报3.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439574439","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439574439?lang=zh_cn&edition=full","pubTime":"2024-05-29 23:42","pubTimestamp":1716997352,"startTime":"0","endTime":"0","summary":"北京时间2024年05月29日23时42分,Neurobo Pharmaceuticals, Inc.股票出现波动,股价急速跳水6.47%。截至发稿,该股报3.90美元/股,成交量4725股,换手率0.10%,振幅4.07%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.83%。Neurobo Pharmaceuticals, Inc.公司简介:NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司,主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529234232968108d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529234232968108d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4202","NRBO","BK4139","OXM"],"gpt_icon":0},{"id":"2438374308","title":"Neurobo Pharmaceuticals, Inc.盘中异动 股价大涨5.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2438374308","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438374308?lang=zh_cn&edition=full","pubTime":"2024-05-28 21:58","pubTimestamp":1716904730,"startTime":"0","endTime":"0","summary":"北京时间2024年05月28日21时58分,Neurobo Pharmaceuticals, Inc.股票出现异动,股价急速上涨5.93%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为1.65%。其相关个股中,Insmed Incorporated、Calliditas Therapeutics Ab、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大,Exicure, Inc.、Mustang Bio, Inc.、Jaguar Health, Inc.较为活跃,换手率分别为49.45%、12.55%、11.19%,振幅较大的相关个股有Exicure, Inc.、G1 Therapeutics, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025,振幅分别为70.52%、21.76%、20.73%。Neurobo Pharmaceuticals, Inc.公司简介:NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司,主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052821585196810400&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052821585196810400&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4202","NRBO","OXM"],"gpt_icon":0},{"id":"2437591296","title":"Neurobo Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2437591296","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437591296?lang=zh_cn&edition=full","pubTime":"2024-05-22 21:35","pubTimestamp":1716384953,"startTime":"0","endTime":"0","summary":"北京时间2024年05月22日21时35分,Neurobo Pharmaceuticals, Inc.股票出现波动,股价快速下跌5.24%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.43%。其相关个股中,Sab Biotherapeutics Inc C/Wts 22/10/2026 、Engene Holdings Inc C/Wts 31/10/2028 Cl A、Rezolute, Inc.涨幅较大,Mustang Bio, Inc.、Biodexa Pharmaceuticals Plc、Coeptis Therapeutics Holdings, Inc.较为活跃,换手率分别为187.89%、95.58%、33.20%,振幅较大的相关个股有Prelude Therapeutics Incorporated、Rezolute, Inc.、Nutriband Inc C/Wts ,振幅分别为13.61%、13.00%、12.90%。Neurobo Pharmaceuticals, Inc.公司简介:NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司,主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522213553aef1177f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522213553aef1177f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NRBO","OXM","BK4202"],"gpt_icon":0},{"id":"2428345644","title":"Neurobo Pharmaceuticals, Inc.盘中异动 股价大涨8.53%报3.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428345644","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2428345644?lang=zh_cn&edition=full","pubTime":"2024-04-17 21:31","pubTimestamp":1713360713,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日21时31分,Neurobo Pharmaceuticals, Inc.股票出现波动,股价急速上涨8.53%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.67%。其相关个股中,Psyence Biomedical Ltd C/Wts 25/01/2029、Vanda Pharmaceuticals Inc.、Viracta Therapeutics, Inc.涨幅较大,Clearmind Medicine Inc.、Novabay Pharmaceuticals, Inc.、Longeveron Inc.较为活跃,换手率分别为25.43%、21.99%、17.23%,振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Viracta Therapeutics, Inc.、Vanda Pharmaceuticals Inc.,振幅分别为25.29%、15.75%、12.10%。Neurobo Pharmaceuticals, Inc.公司简介:NeuroBo Pharmaceuticals Inc 是一家临床阶段的生物技术公司,主要专注于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417213153878a137b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417213153878a137b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4202","OXM","BK4139","NRBO"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.neurobopharma.com","stockEarnings":[{"period":"1week","weight":0.1127},{"period":"1month","weight":0.1916},{"period":"3month","weight":0.1552},{"period":"6month","weight":0.1073},{"period":"1year","weight":0.2983},{"period":"ytd","weight":0.2282}],"compareEarnings":[{"period":"1week","weight":0.0048},{"period":"1month","weight":0.0341},{"period":"3month","weight":0.0511},{"period":"6month","weight":0.1633},{"period":"1year","weight":0.2302},{"period":"ytd","weight":0.1473}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"NeuroBo Pharmaceuticals, Inc.于2008年11月10日在密歇根以Michigan Life Therapeutics, LLC (MLT)这个名字注册成立。NeuroBo Pharmaceuticals, Inc.是一家临床阶段的生物技术公司,主要致力于开发和商业化治疗心脏代谢疾病的新药物。NeuroBo有两个主要项目,重点治疗非酒精性脂肪性肝炎(NASH)、肥胖症和2型糖尿病(T2D)。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.101843},{"month":2,"riseRate":0.375,"avgChangeRate":0.080599},{"month":3,"riseRate":0.5,"avgChangeRate":-0.020088},{"month":4,"riseRate":0.375,"avgChangeRate":-0.098642},{"month":5,"riseRate":0.25,"avgChangeRate":-0.104755},{"month":6,"riseRate":0.625,"avgChangeRate":0.103229},{"month":7,"riseRate":0.25,"avgChangeRate":-0.010277},{"month":8,"riseRate":0.142857,"avgChangeRate":-0.23779},{"month":9,"riseRate":0.375,"avgChangeRate":0.039055},{"month":10,"riseRate":0.125,"avgChangeRate":-0.215957},{"month":11,"riseRate":0.375,"avgChangeRate":-0.112459},{"month":12,"riseRate":0.125,"avgChangeRate":-0.172588}],"exchange":"NASDAQ","name":"NeuroBo Pharmaceuticals, Inc.","nameEN":"NeuroBo Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"NeuroBo Pharmaceuticals, Inc.(NRBO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供NeuroBo Pharmaceuticals, Inc.(NRBO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"NeuroBo Pharmaceuticals, Inc.,NRBO,NeuroBo Pharmaceuticals, Inc.股票,NeuroBo Pharmaceuticals, Inc.股票老虎,NeuroBo Pharmaceuticals, Inc.股票老虎国际,NeuroBo Pharmaceuticals, Inc.行情,NeuroBo Pharmaceuticals, Inc.股票行情,NeuroBo Pharmaceuticals, Inc.股价,NeuroBo Pharmaceuticals, Inc.股市,NeuroBo Pharmaceuticals, Inc.股票价格,NeuroBo Pharmaceuticals, Inc.股票交易,NeuroBo Pharmaceuticals, Inc.股票购买,NeuroBo Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"NeuroBo Pharmaceuticals, Inc.(NRBO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供NeuroBo Pharmaceuticals, Inc.(NRBO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}